{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:27:05Z","timestamp":1771511225555,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00520-015-2935-y","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T09:28:19Z","timestamp":1442568499000},"page":"1571-1581","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study"],"prefix":"10.1007","volume":"24","author":[{"given":"Susana","family":"Pereira","sequence":"first","affiliation":[]},{"given":"Filipa","family":"Fontes","sequence":"additional","affiliation":[]},{"given":"Teresa","family":"Sonin","sequence":"additional","affiliation":[]},{"given":"Teresa","family":"Dias","sequence":"additional","affiliation":[]},{"given":"Maria","family":"Fragoso","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 M.","family":"Castro-Lopes","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Lunet","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"2935_CR1","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer. [ http:\/\/globocan.iarc.fr\/ ] (Accessed on 1 January 2015)"},{"issue":"1","key":"2935_CR2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","volume":"15","author":"R Angelis De","year":"2014","unstructured":"De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R (2014) Cancer survival in Europe 1999\u20132007 by country and age: results of EUROCARE\u20145-a population-based study. Lancet Oncol 15(1):23\u201334","journal-title":"Lancet Oncol"},{"key":"2935_CR3","unstructured":"Howlader N, Noone A, Krapcho M, Garshell J, Neyman N, Altekruse S, et al. (2013) SEER Cancer Statistics Review, 1975\u20132011, National Cancer Institute. Bethesda, MD: SEER. Available from: [ http:\/\/seer.cancer.gov\/csr\/1975_2011\/ ] (Accessed on 1 November 2014)"},{"issue":"7","key":"2935_CR4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ctrv.2014.04.004","volume":"40","author":"NC Miltenburg","year":"2014","unstructured":"Miltenburg NC, Boogerd W (2014) Chemotherapy-induced neuropathy: a comprehensive survey. Cancer Treat Rev 40(7):872\u2013882","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"2935_CR5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10549-010-1278-0","volume":"125","author":"DL Hershman","year":"2011","unstructured":"Hershman DL, Weimer LH, Wang A, Kranwinkel G, Brafman L, Fuentes D, Awad D, Crew KD (2011) Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res Treat 125(3):767\u2013774","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2935_CR6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejca.2014.11.024","volume":"51","author":"L Eckhoff","year":"2015","unstructured":"Eckhoff L, Knoop A, Jensen M, Ewertz M (2015) Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors. Eur J Cancer 51(3):292\u2013300","journal-title":"Eur J Cancer"},{"issue":"1\u20133","key":"2935_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2011.10.019","volume":"291","author":"AS Jaggi","year":"2012","unstructured":"Jaggi AS, Singh N (2012) Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology 291(1\u20133):1\u20139","journal-title":"Toxicology"},{"issue":"29","key":"2935_CR8","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.2174\/092986708786848569","volume":"15","author":"SB Park","year":"2008","unstructured":"Park SB, Krishnan AV, Lin CS, Goldstein D, Friedlander M, Kiernan MC (2008) Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies. Curr Med Chem 15(29):3081\u20133094","journal-title":"Curr Med Chem"},{"issue":"1","key":"2935_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1529-8027.2008.00156.x","volume":"13","author":"AJ Windebank","year":"2008","unstructured":"Windebank AJ, Grisold W (2008) Chemotherapy-induced neuropathy. J Peripher Nerv Syst 13(1):27\u201346","journal-title":"J Peripher Nerv Syst"},{"issue":"12","key":"2935_CR10","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461\u20132470","journal-title":"Pain"},{"issue":"5","key":"2935_CR11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/0284186X.2014.995775","volume":"54","author":"M Ewertz","year":"2015","unstructured":"Ewertz M, Qvortrup C, Eckhoff L (2015) Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives. Acta Oncol 54(5):587\u2013591","journal-title":"Acta Oncol"},{"issue":"5","key":"2935_CR12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/CAD.0000000000000051","volume":"25","author":"D Kudlowitz","year":"2014","unstructured":"Kudlowitz D, Muggia F (2014) Clinical features of taxane neuropathy. Anti-Cancer Drugs 25(5):495\u2013501","journal-title":"Anti-Cancer Drugs"},{"issue":"4","key":"2935_CR13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00280-014-2607-5","volume":"75","author":"E Rivera","year":"2015","unstructured":"Rivera E, Cianfrocca M (2015) Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer. Cancer Chemother Pharmacol 75(4):659\u2013670","journal-title":"Cancer Chemother Pharmacol"},{"key":"2935_CR14","doi-asserted-by":"crossref","unstructured":"De Iuliis F, Taglieri L, Salerno G, Lanza R, Scarpa S (2015) Taxane induced neuropathy in patients affected by breast cancer: literature review. Crit Rev Oncol Hematol","DOI":"10.1016\/j.critrevonc.2015.04.011"},{"issue":"5","key":"2935_CR15","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00520-012-1667-5","volume":"21","author":"B Vincenzi","year":"2013","unstructured":"Vincenzi B, Frezza AM, Schiavon G, Spoto C, Silvestris N, Addeo R, Catalano V, Graziano F, Santini D, Tonini G (2013) Identification of clinical predictive factors of Oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV. Support Care Cancer 21(5):1313\u20131319","journal-title":"Support Care Cancer"},{"issue":"4","key":"2935_CR16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/annonc\/mdp509","volume":"21","author":"RK Ramanathan","year":"2010","unstructured":"Ramanathan RK, Rothenberg ML, de Gramont A, Tournigand C, Goldberg RM, Gupta S, Andre T (2010) Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies. Ann Oncol 21(4):754\u2013758","journal-title":"Ann Oncol"},{"issue":"4","key":"2935_CR17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.6004\/jnccn.2015.0057","volume":"13","author":"BP Morena de la","year":"2015","unstructured":"de la Morena BP, Conesa MA, Gonzalez-Billalabeitia E, Urrego E, Garcia-Garre E, Garcia-Martinez E, Poves MZ, Vicente V, de la Pena FA (2015) Delayed recovery and increased severity of paclitaxel-induced peripheral neuropathy in patients with diabetes. J Natl Compr Cancer Netw 13(4):417\u2013423","journal-title":"J Natl Compr Cancer Netw"},{"issue":"4","key":"2935_CR18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.clcc.2012.05.002","volume":"11","author":"AN Uwah","year":"2012","unstructured":"Uwah AN, Ackler J, Leighton JC Jr, Pomerantz S, Tester W (2012) The effect of diabetes on oxaliplatin-induced peripheral neuropathy. Clin Colorectal Cancer 11(4):275\u2013279","journal-title":"Clin Colorectal Cancer"},{"issue":"10","key":"2935_CR19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006301","volume":"4","author":"S Pereira","year":"2014","unstructured":"Pereira S, Fontes F, Sonin T, Dias T, Fragoso M, Castro-Lopes J, Lunet N (2014) Neurological complications of breast cancer: study protocol of a prospective cohort study. BMJ Open 4(10), e006301","journal-title":"BMJ Open"},{"issue":"9","key":"2935_CR20","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/13803395.2011.589374","volume":"33","author":"S Freitas","year":"2011","unstructured":"Freitas S, Simoes MR, Alves L, Santana I (2011) Montreal cognitive assessment (MoCA): normative study for the Portuguese population. J Clin Exp Neuropsychol 33(9):989\u2013996","journal-title":"J Clin Exp Neuropsychol"},{"issue":"5","key":"2935_CR21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365\u2013376","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2935_CR22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193\u2013213","journal-title":"Psychiatry Res"},{"issue":"6","key":"2935_CR23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361\u2013370","journal-title":"Acta Psychiatr Scand"},{"key":"2935_CR24","unstructured":"CTCAE (2010) Cancer Therapy Evaluation Program, Common terminology criteria for adverse events, version 4.0. DCTD, NCI, NIH, DHHS, [ http:\/\/ctep.cancer.gov\/ ] (Accessed on 1 January 2012)."},{"issue":"8","key":"2935_CR25","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.53.8.1660","volume":"53","author":"DR Cornblath","year":"1999","unstructured":"Cornblath DR, Chaudhry V, Carter K, Lee D, Seysedadr M, Miernicki M, Joh T (1999) Total neuropathy score: validation and reliability study. Neurology 53(8):1660\u20131664","journal-title":"Neurology"},{"issue":"18","key":"2935_CR26","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","volume":"70","author":"RD Treede","year":"2008","unstructured":"Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70(18):1630\u20131635","journal-title":"Neurology"},{"issue":"4","key":"2935_CR27","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1529-8027.2010.00292.x","volume":"15","author":"KA Griffith","year":"2010","unstructured":"Griffith KA, Merkies IS, Hill EE, Cornblath DR (2010) Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties. J Peripher Nerv Syst 15(4):314\u2013325","journal-title":"J Peripher Nerv Syst"},{"issue":"10","key":"2935_CR28","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1200\/JCO.2005.04.0543","volume":"24","author":"JJ Lee","year":"2006","unstructured":"Lee JJ, Swain SM (2006) Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol 24(10):1633\u20131642","journal-title":"J Clin Oncol"},{"key":"2935_CR29","first-page":"107","volume":"15","author":"EK Rowinsky","year":"1993","unstructured":"Rowinsky EK, Chaudhry V, Cornblath DR, Donehower RC (1993) Neurotoxicity of taxol. J Natl Cancer Inst Monogr 15:107\u2013115","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"1","key":"2935_CR30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10549-013-2728-2","volume":"142","author":"L Eckhoff","year":"2013","unstructured":"Eckhoff L, Knoop AS, Jensen MB, Ejlertsen B, Ewertz M (2013) Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer. Breast Cancer Res Treat 142(1):109\u2013118","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"2935_CR31","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3109\/0284186X.2011.602111","volume":"50","author":"L Eckhoff","year":"2011","unstructured":"Eckhoff L, Nielsen M, Moeller S, Knoop A (2011) TAXTOX\u2014a retrospective study regarding the side effects of docetaxel given as part of the adjuvant treatment to patients with primary breast cancer in Denmark from 2007 to 2009. Acta Oncol 50(7):1075\u20131082","journal-title":"Acta Oncol"},{"issue":"1","key":"2935_CR32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007853","volume":"249","author":"S Quasthoff","year":"2002","unstructured":"Quasthoff S, Hartung HP (2002) Chemotherapy-induced peripheral neuropathy. J Neurol 249(1):9\u201317","journal-title":"J Neurol"},{"issue":"8","key":"2935_CR33","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00520-014-2255-7","volume":"22","author":"F Mols","year":"2014","unstructured":"Mols F, Beijers T, Vreugdenhil G, van de Poll-Franse L (2014) Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer 22(8):2261\u20132269","journal-title":"Support Care Cancer"},{"issue":"7","key":"2935_CR34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3816\/CBC.2007.n.010","volume":"7","author":"A Pace","year":"2007","unstructured":"Pace A, Nistico C, Cuppone F, Bria E, Galie E, Graziano G, Natoli G, Sperduti I, Jandolo B, Calabretta F, Tomao S, Terzoli E (2007) Peripheral neurotoxicity of weekly paclitaxel chemotherapy: a schedule or a dose issue? Clin Breast Cancer 7(7):550\u2013554","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"2935_CR35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00520-005-0868-6","volume":"14","author":"AA Argyriou","year":"2006","unstructured":"Argyriou AA, Polychronopoulos P, Koutras A, Iconomou G, Gourzis P, Assimakopoulos K, Kalofonos HP, Chroni E (2006) Is advanced age associated with increased incidence and severity of chemotherapy-induced peripheral neuropathy? Support Care Cancer 14(3):223\u2013229","journal-title":"Support Care Cancer"},{"issue":"1","key":"2935_CR36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1212\/WNL.47.1.115","volume":"47","author":"RJ Freilich","year":"1996","unstructured":"Freilich RJ, Balmaceda C, Seidman AD, Rubin M, DeAngelis LM (1996) Motor neuropathy due to docetaxel and paclitaxel. Neurology 47(1):115\u2013118","journal-title":"Neurology"},{"issue":"2","key":"2935_CR37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/jns5.12064","volume":"19","author":"KA Griffith","year":"2014","unstructured":"Griffith KA, Dorsey SG, Renn CL, Zhu S, Johantgen ME, Cornblath DR, Argyriou AA, Cavaletti G, Merkies IS, Alberti P, Postma TJ, Rossi E, Frigeni B, Bruna J, Velasco R, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galie E, Briani C, Dalla Torre C, Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey DJ, Kerrigan S, Schenone A, Fabbri S, Valsecchi MG (2014) Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study. J Peripher Nerv Syst 19(2):127\u2013135","journal-title":"J Peripher Nerv Syst"},{"issue":"21","key":"2935_CR38","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1158\/0008-5472.CAN-14-2060","volume":"74","author":"BM Carvalho de","year":"2014","unstructured":"de Carvalho BM, Kosturakis AK, Eng C, Wendelschafer-Crabb G, Kennedy WR, Simone DA, Wang XS, Cleeland CS, Dougherty PM (2014) A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy. Cancer Res 74(21):5955\u20135962","journal-title":"Cancer Res"},{"issue":"11","key":"2935_CR39","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1158\/1078-0432.CCR-12-0205","volume":"18","author":"JA Boyette-Davis","year":"2012","unstructured":"Boyette-Davis JA, Eng C, Wang XS, Cleeland CS, Wendelschafer-Crabb G, Kennedy WR, Simone DA, Zhang H, Dougherty PM (2012) Subclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapy. Clin Cancer Res 18(11):3180\u20133187","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2935_CR40","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00280-013-2152-7","volume":"71","author":"EG Vichaya","year":"2013","unstructured":"Vichaya EG, Wang XS, Boyette-Davis JA, Mendoza TR, He Z, Thomas SK, Shah N, Williams LA, Cleeland CS, Dougherty PM (2013) Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy. Cancer Chemother Pharmacol 71(6):1531\u20131540","journal-title":"Cancer Chemother Pharmacol"},{"issue":"28","key":"2935_CR41","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1200\/JCO.2013.54.5418","volume":"32","author":"AK Kosturakis","year":"2014","unstructured":"Kosturakis AK, He Z, Li Y, Boyette-Davis JA, Shah N, Thomas SK, Zhang H, Vichaya EG, Wang XS, Wendelschafer-Crabb G, Kennedy WR, Simone DA, Cleeland CS, Dougherty PM (2014) Subclinical peripheral neuropathy in patients with multiple myeloma before chemotherapy is correlated with decreased fingertip innervation density. J Clin Oncol 32(28):3156\u20133162","journal-title":"J Clin Oncol"},{"issue":"9","key":"2935_CR42","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1007\/s00415-012-6442-5","volume":"259","author":"K Osmani","year":"2012","unstructured":"Osmani K, Vignes S, Aissi M, Wade F, Milani P, Levy BI, Kubis N (2012) Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation. J Neurol 259(9):1936\u20131943","journal-title":"J Neurol"},{"issue":"5","key":"2935_CR43","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1158\/1078-0432.CCR-04-1655","volume":"11","author":"ID Davis","year":"2005","unstructured":"Davis ID, Kiers L, MacGregor L, Quinn M, Arezzo J, Green M, Rosenthal M, Chia M, Michael M, Bartley P, Harrison L, Daly M (2005) A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy. Clin Cancer Res 11(5):1890\u20131898","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2935_CR44","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/cncr.28654","volume":"120","author":"AD Leal","year":"2014","unstructured":"Leal AD, Qin R, Atherton PJ, Haluska P, Behrens RJ, Tiber CH, Watanaboonyakhet P, Weiss M, Adams PT, Dockter TJ, Loprinzi CL (2014) North Central Cancer Treatment Group\/Alliance trial N08CA\u2014the use of glutathione for prevention of paclitaxel\/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study. Cancer 120(12):1890\u20131897","journal-title":"Cancer"},{"issue":"20","key":"2935_CR45","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1200\/JCO.2012.44.8738","volume":"31","author":"DL Hershman","year":"2013","unstructured":"Hershman DL, Unger JM, Crew KD, Minasian LM, Awad D, Moinpour CM, Hansen L, Lew DL, Greenlee H, Fehrenbacher L, Wade JL 3rd, Wong SF, Hortobagyi GN, Meyskens FL, Albain KS (2013) Randomized double-blind placebo-controlled trial of acetyl-l-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. J Clin Oncol 31(20):2627\u20132633","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2935-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-015-2935-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2935-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:09:45Z","timestamp":1559095785000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-015-2935-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,18]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["2935"],"URL":"https:\/\/doi.org\/10.1007\/s00520-015-2935-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,18]]}}}